Join us at World ADC 2025
AI Pathology and Spatial Biomarker Solutions for Clinical Trials and Diagnostics
Enabling next-gen diagnostics for ADCs, multi-specifics, and IO.
Talk:
Novel AI Spatial Platform to Inform Your ADC Biomarker Strategy
- Date: Tuesday, November 4, 2025
- Time: 2:30 PM PT
Speaking Points:
- Understand the complexity of ADC therapies, including their intricate mechanisms of action, the challenges posed by tumor heterogeneity, the role of the tumor microenvironment, and the impact of the bystander effect.
- Demonstrate how computational pathology can better stratify patients most likely to benefit from ADC therapy.
- See how an AI-enhanced pipeline can help better identify targets for ADC and emerging multi-specific therapies.
Speaker
Ken Bloom, MD, FCAP
Head of Pathology
Nucleai
Book a Meeting with Us
Byron Lawson
VP, Pharma BD & Strategic Partnerships
Ken Bloom
Head of Pathology
Please complete the form below to schedule a meeting with our team at World ADC 2025